MD NET — RALPH PARCHMENT (LEIDOS BIOMEDICAL RESEARCH, INC.)
The Division of Cancer Treatment and Diagnosis, NCI (DCTD) has embarked on a strategic initiative in its National Clinical Trials Network (NCTN) to define and discover new treatments for patients with
| Project title | MD NET |
|---|---|
| Project number | 75N91019D00024-P00005-759101900139-1 |
| PI name | RALPH PARCHMENT |
| Institution | LEIDOS BIOMEDICAL RESEARCH, INC. |
| Funding mechanism | N01 |
| Agency | NCI |
| Award amount | $33.47M |
| Fiscal year | 2023 |
| Project start | 2019-09-30T00:00:00 |
| Project end | 2028-09-29T00:00:00 |
| Abstract | The Division of Cancer Treatment and Diagnosis, NCI (DCTD) has embarked on a strategic initiative in its National Clinical Trials Network (NCTN) to define and discover new treatments for patients with |
| Key terms | <AML/MDS><Area><Assay><Authorization><Authorization documentation><Bioassay><Biologic Assays><Biolog |
$799/mo
Try GrantRadar →